Canbi Pharma Tech Limited
1025967-78-5 Liftegrast
1025967-78-5 Liftegrast
1025967-78-5 Liftegrast

1025967-78-5 Liftegrast

CAS:1025967-78-5
MF:C29H24Cl2N2O7S
MW:615.48
EINECS:813-044-8
MDL No.:MFCD28502439

Send Inquiry
Description

Properties

Appearance White to Off-White Solid
Melting point:>163°C (dec.)
Boiling point:811.9±65.0 °C
Density 1.479±0.06 g/cm3
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere

 

Application:

    Lifitegrast reduces the aggregation of white blood cells in the eye by blocking the interaction between LFA-1 and ICAM-1, thereby alleviating eye inflammation and dry eye symptoms. This mechanism makes Lifitegrast have potential in the treatment of dry eye disease.

Detailed Applications

1. Clinical Pharmaceutical

▶ First FDA-approved prescription drug for treating signs and symptoms of moderate to severe Dry Eye Disease (DED).

▶ Acts as a novel small-molecule LFA-1 (lymphocyte function-associated antigen-1) antagonist, inhibits LFA-1/ICAM-1 binding, blocks ocular surface inflammatory response, relieves dryness, irritation, burning, redness and blurred vision caused by DED.

▶ Unique mechanism: targets the inflammatory root of dry eye, not just symptomatic relief, with long-term therapeutic effect.

 

2. Pharmaceutical API Production

▶ Active pharmaceutical ingredient (API) for manufacturing Xiidra® (the commercial eye drop preparation of Lifitegrast).

 

3. Biomedical Research

▶ Used in laboratory research of ocular inflammation, T cell-mediated immune diseases, corneal injury and diabetic retinal complications.

▶ Applied in anti-inflammatory drug development and integrin receptor antagonist mechanism research (IC50=2.98 nM for LFA-1 inhibition).

Packaging Specifications

 ▶ Commercial Finished Product (Xiidra® Ophthalmic Solution)

1. Primary packaging: Sterile low-density polyethylene (LDPE) single-use vials, 0.2mL per vial (contains 10mg Lifitegrast active ingredient).

2. Secondary packaging: Aluminum foil light-proof bags, 5 vials/bag or 60 vials/box (standard clinical package).

3. Sealing: Tamper-evident seal, sterile aseptic packaging to prevent microbial contamination.

 

▶ API Raw Material Packaging (Industrial/Lab Grade)

1. Lab-scale packaging: Amber glass vials with Teflon-lined caps, specifications: 5mg, 10mg, 25mg, 50mg, 100mg, 500mg (purity ≥99%).

2. Industrial production packaging: HDPE plastic drums/fiber drums with inner PE film, 1kg, 5kg, 25kg per drum; vacuum-sealed for moisture proof.

 

▶ Storage & Shelf Life Requirements

1. Finished eye drops: Store at 20°C-25°C (68°F-77°F), allow brief 15°C-30°C storage; avoid direct sunlight, freezing and high humidity; shelf life 24 months in original packaging.

2. API raw material: Sealed storage at 2°C-8°C (cold chain), dry and anaerobic environment; shelf life 18 months under standard storage; normal transportation for bulk goods, cold chain for small batch lab products.

 

Synonyms:

Lifitegrast

1025967-78-5

Xiidra

SAR-1118

(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid

SHP-606

L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-

SAR1118

L-Phenylalanine, N-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-

(2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6-yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid

(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid

Lifitegrast 

lifitegrastum

L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-; N-[[2-(6-Benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-L-phenylalanine; (S)

N-(2-(1-benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(methanesulfonyl)-L-phenylalanine

(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid

(2S)-2-(((2-(Benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid

 

 

 

Hot Tags: 1025967-78-5 liftegrast, China 1025967-78-5 liftegrast manufacturers, suppliers, api local api integration, api deployment, api role based access control api integration, api compatibility, api voice assistant powered api integration, api multi factor authentication api integration

Inquiry
goTop

(0/10)

clearall